BioSpace News Archive

miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced the pricing of an underwritten public offering of 15,000,000 shares of its common stock and warrants to purchase up to an aggregate of 7,500,000 shares of its common stock.

Infiniti Research, a leading market intelligence solutions provider, has recently announced the completion of its latest success story on marketing solutions.

REHOVOT, Israel, Feb. 07, 2020 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro-diagnostics company focused on the development of blood tests for the early detection of cancer and neurodegenerative disorders, today released a letter to shareholders: Dear Shareholders, Thank you for continuing to support the Company as we embark on this effort to transform into a US-focused blood diagnostics company preparing to embark on a clinical utility study

Innophos Holdings, Inc., a leading international producer of essential ingredients, announced the completion of its acquisition by an affiliate of One Rock Capital Partners, LLC, a leading middle-market private equity firm.

Feb. 7, 2020 14:19 UTC LONDON--( BUSINESS WIRE )-- A well-known market intelligence company, Infiniti Research, has worked with 100+ companies in the healthcare industry across the globe. Our expertise in the field of healthcare market research enables us to offer tailored solutions that empower healthcare providers to become well-positioned for the future. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/202002070052

The ANSI National Accreditation Board (ANAB), a wholly owned subsidiary of the American National Standards Institute (ANSI), has launched a new pilot accreditation program for the Global Retail and Manufacturer Alliance (GRMA) certification scheme.

As part of its expansion into human health, GreenLight Biosciences, Inc. is pleased to welcome the first members of its new Life Sciences Advisory Board.

Cerner Corporation (NASDAQ: CERN), a global health care technology company, has achieved 2020 Best in KLAS honors, recognizing the company’s outstanding efforts in three distinct areas to help health care professionals deliver better patient care. KLAS Research, a leading health care IT data insights company, has named Cerner Best in KLAS for Most Improved Physician Practices and Global Acute Care EMR for the Middle East/Africa market for the second year in a row.

CorMatrix®Cardiovascular, Inc. www.cormatrix.com, a leading developer of regenerative cardiovascular medical devices, today announced receiving FDA approval to expand and enroll 20 additional patients in the adult arm, including up to 4 additional cardiac surgery research and investigative centers, for its early feasibility IDE study of the Cor® TRICUSPID ECM® valve* for pediatric and adult patients.

Rare Disease Patients will receive Whole Genome Sequencing with Rare Disease Reports for $299 (€289). Patient Groups are encouraged to contact Dante Labs to develop personalized reports for their members (ex. Epilepsy Report for Epilepsy Groups).